Picture1

Spruce Biosciences and Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan

Partnership aims to accelerate global development and commercialization plans for tildacerfont to address worldwide unmet medical need in congenital adrenal...

logo-36

Outlook on the $20.5 Billion PoS Displays Global Market to 2027 – China is Forecast to Grow at an 8.7% CAGR – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "PoS Displays: Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for PoS Displays...